Argent Development Group

Quadriga BioSciences is a leading biotechnology company based in Los Altos, CA, dedicated to advancing the clinical development of QBS72S. With a team of experienced leaders, founders, industry advisors, and a board of directors, Quadriga BioSciences is at the forefront of scientific innovation in the field. Through their commitment to research and development, Quadriga BioSciences aims to make significant contributions to the healthcare industry. As an actively seeking partner, Quadriga BioSciences invites interested parties to join them in their mission to advance the clinical development of QBS72S. With a focus on investor information, corporate partnerships, and media engagement, Quadriga BioSciences is poised to make a lasting impact in the biotechnology sector. Generated from the website

RenovoRx is a life sciences company dedicated to developing innovative targeted oncology therapies, focusing on addressing high unmet medical needs in cancer treatment. Their flagship product, RenovoCath, is an FDA-cleared drug-delivery device designed to enhance the intra-arterial administration of chemotherapy, specifically targeting locally advanced pancreatic cancer. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform aims to improve the effectiveness and safety of cancer therapies by delivering treatment directly to tumor sites while minimizing systemic side effects. Currently, RenovoRx is conducting a Phase III clinical trial, TIGeR-PaC, to evaluate the efficacy of its combination oncology product candidate against standard intravenous chemotherapy options. Generated from the website